“…Ischemic injury of the brain is the cumulative result of several pathologies: The primary metabolic impact pro voked by the reduction of blood flow is aggravated by secondary complicating disturbances, involving such dif ferent mechanisms as free radical-mediated membrane injury (Siesjo et aI" 1989;Schmidley, 1990), uncoupling of oxidative respiration (Katsura et aI" 1994;Abe et aI" 1995), inflammatory reactions (Shiga et aI" 1991), peri focal depolarizations (Iijima et aI" 1992;Nedergaard and water declined to below 80% of controll steadily increased by -50% during the initial 6 h of vascular occlusion relative to the first set of data 10 min postocclusion, In the treated animals, in contrast, the ADC lesion volume declined by -20% during the same intervaL Treatment also led to a significant reduction in the number of periinfarct depolarizations, After 6 h of vascular occlusion, blood flow was significantly higher in the treated animals, and the volume of ATP-depleted and morphologically injured tissue representing the infarct core was 60-70% smaller. The volume of severely acidic tissue, in contrast, did not differ, indicating that LOE 908 MS does not reduce the size of ischemic penumbra, These findings demonstrate that post occlusion treatment of permanent focal ischemia with LOE 908 MS delays the expansion of the infarct core into the penumbra for a duration of at least 6 h and therefore substantially pro longs the window of opportunity for the reversal of the isch emic impact in the peripheral parts of the evolving infarct.…”